FDA releases its Plant and Animal Biotechnology Innovation Action Plan

FDA releases its Plant and Animal Biotechnology Innovation Action Plan

The Food and Drug Administration (FDA) recently released its Plant and Animal Biotechnology Innovation Action Plan, which provides an overview of FDA’s efforts to develop a comprehensive policy framework for the oversight of animal biotechnology products, including food and drug products derived from intentionally genetically altered animals and plants.

Read More

US National Nanotechnology Initiative holds Second Quantitative Estimate of Exposure to Nanomaterials Conference (QEEN II) Oct 9-10

US National Nanotechnology Initiative holds Second Quantitative Estimate of Exposure to Nanomaterials Conference (QEEN II) Oct 9-10

Jo Anne Shatkin, as well as new team members Dr. Shaun Clancy, and Cassidy Pomeroy-Carter were part of the planning and coordination of the conference, organizing panel discussions on exposure to nanomaterials in food and food contact items, and stakeholder perspectives, respectively.

Read More